9hon MSN
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...
14h
Zacks Investment Research on MSNLLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Welcome to the UK's Official Charts! In addition to the Official Singles and Albums Chart, did you know the Official Charts Company compiles 50+ charts every week, spanning different genres and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results